It does indicate that off label prescriptions are in the decline over the course of the study with 3% prescribed to women at its best- decline may be due to more information on the negative effects of a toxicity.
From the androgel website, it's still not recommended in women:
"AndroGel 1% is not meant for use in women and must not be used in women who are pregnant, may become pregnant, or are breastfeeding. AndroGel 1% may harm the unborn or breastfeeding baby. Women who are pregnant or who may become pregnant should avoid contact with the area of skin where AndroGel 1% has been applied. "
I personally didn't see the commercial, but contact exposure to hormone creams/gels etc is a big problem given ease of exposure- could be typical fine print so they're not liable if they're used off label.
You do raise a valid point on their ability to use safety study, however, I think the method of use patent may prevent them from using it.
-RG
